Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1252072Generated: November 2, 2026

Dimethylformamide → 4-[4-(3-Indolyl)piperidinomethyl]-2-mesylaminothiazole

https://huagongshe.com/reaction/1252072

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDimethylformamideHCID 6228—
ReactantTriethylamineHCID 8471—
ReactantMethanesulfonyl chlorideHCID 31297—
Reactant4-((4-(1H-Indol-3-yl)piperidin-1-yl)methyl)thiazol-2-amineHCID 14129796—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
Product4-[4-(3-Indolyl)piperidinomethyl]-2-mesylaminothiazoleHCID 9800584—

Reaction Steps

To a mixture of 2-amino-4-[4-(3-indolyl)piperidinomethyl]thiazole (1.73 g), triethylamine (3.1 ml) and N,N-dimethylformamide (15 ml) was added dropwise a solution of mesyl chloride (0.86 ml) in methylene chloride (1 ml) at 5° to 7° C. with stirring. The mixture was further stirred at that temperature for 2 hours, after which a solution of mesyl chloride (0.34 ml) in methylene chloride (0.5 ml) was added. The reaction mixture was further stirred at the same temperature for 1.5 hours. Following addition of water (50 ml), the reaction mixture was extracted with a mixture of chloroform and methanol (60 ml, 10:1 V/V) twice. The extract was washed with a saturated aqueous solution of sodium chloride, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was dissolved in tetrahydrofuran (40 ml) and, then, 10% aqueous sodium hydroxide solution (20 ml) was added gradually thereto. The mixture was stirred at ambient temperature overnight. The reaction mixture was then adjusted to pH 7.0 with diluted hydrochloric acid and extracted with a mixture of chloroform and methanol (100 ml, 10:1 V/V). The organic layer was separated, washed with water, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was subjected to column chromatography on silica gel, followed by elution with a mixture of chloroform and methanol (10:1 V/V). The eluate gave 4-[4-(3-indolyl)piperidinomethyl]-2-mesylaminothiazole (480 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04742057
Source datasetuspto-grants-1988_05
ORD IDord-75a0dc787c494a05a58a7266cd1c18a2
Source noteuspto-grants-1988_05